Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


<i>Pseudomonas aeruginosa</i>: Current & Future Treatment Options
Marin H. Kollef, MD, discusses treatment options for Pseudomonas aeruginosa.
The Escalating Problem & Cost of Antimicrobial Resistance
Glenn Tillotson, PhD, FIDSA, provides insight into the growing problem and cost of antimicrobial resistance.
MDR Infections: Current Pathogen and Treatment Paradigm
Peter L. Salgo, MD; Andrew Shorr, MD; Jason Pogue, PharmD, BCPS-AQID; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); and Debra Goff, PharmD, FCCP, identify the currently prevalent multidrug-resistant bacterial infections, which of these infections have benefited from the development of newer agents, and how treatment approaches may change with the advent of antibiotic stewardships.
Understanding the Causes and Impact of MDR Infections
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); and Debra Goff, PharmD, FCCP, speculate on the causes behind multidrug-resistant bacterial infections and identify how these infections are impacting patients of all populations.
What Are the Next Steps for Ridinilazole?
Dr. Richard Vickers, discusses what the next steps are for Summit Therapeutic’s ridinilazole.
What to Consider When Calling For Cultures
Marin H. Kollef, MD, discusses what to consider when calling for cultures.
Community Sources of <i>Clostridium difficile</i>
Following a general discussion on risk factors for Clostridium difficile, Lawrence J. Brandt, MD; Erik Dubberke, MD; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, distinguish which factors increase the likelihood for community onset.
Antimicrobial Stewardship Programs: A Necessary Component of Health Care
Debra Goff, PharmD, FCCP, explains the role that antimicrobial stewardship programs have in the fight against multidrug-resistant infections.
Big advances in treatment can